First Time Loading...
J

Jinyu Bio-Technology Co Ltd
SSE:600201

Watchlist Manager
Jinyu Bio-Technology Co Ltd
SSE:600201
Watchlist
Price: 9.14 CNY 2.24% Market Closed
Updated: May 2, 2024

Jinyu Bio-Technology Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jinyu Bio-Technology Co Ltd
Operating Income Peer Comparison

Comparables:
6160
1801
603392
S
002252
300122

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
J
Jinyu Bio-Technology Co Ltd
SSE:600201
Operating Income
¥287.7m
CAGR 3-Years
-7%
CAGR 5-Years
-21%
CAGR 10-Years
3%
Beigene Ltd
HKEX:6160
Operating Income
-¥12B
CAGR 3-Years
-21%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Operating Income
-¥1.1B
CAGR 3-Years
-36%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Operating Income
¥1.4B
CAGR 3-Years
22%
CAGR 5-Years
55%
CAGR 10-Years
N/A
S
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Operating Income
¥2B
CAGR 3-Years
32%
CAGR 5-Years
23%
CAGR 10-Years
22%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Operating Income
¥9.9B
CAGR 3-Years
38%
CAGR 5-Years
46%
CAGR 10-Years
47%

See Also

What is Jinyu Bio-Technology Co Ltd's Operating Income?
Operating Income
287.7m CNY

Based on the financial report for Sep 30, 2023, Jinyu Bio-Technology Co Ltd's Operating Income amounts to 287.7m CNY.

What is Jinyu Bio-Technology Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
3%

Over the last year, the Operating Income growth was 60%. The average annual Operating Income growth rates for Jinyu Bio-Technology Co Ltd have been -7% over the past three years , -21% over the past five years , and 3% over the past ten years .